Contact this trialFirst, we need to learn more about you.
Protease Inhibitor
AT1001 for Coronavirus
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial is testing a new drug to see if it can help people with early signs of MIS-C who are at high risk of progression. The drug is given four times a day.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.